CRVS stock news

CRVS stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

5 wire items

2026-09-10 18:58:12 UTC#294512duplicateconfirmednews

Corvus Pharmaceuticals (CRVS) reiterates soquelitinib clinical trial readout schedule through 2028

quartrimportance 0.30trust 0.50Corvus Pharmaceuticals, Inc. +0.30Soquelitinib +0.30

2026-09-10 18:06:26 UTC#294267newconfirmednews

Corvus Pharmaceuticals (CRVS) outlines soquelitinib clinical readout timeline through 2028

quartrimportance 0.40trust 0.60Corvus Pharmaceuticals, Inc. +0.40soquelitinib +0.40Peripheral T-cell lymphoma +0.30+2 entities

2026-08-07 08:45:14 UTC#143477newconfirmednews

Corvus Pharmaceuticals sets Q1 2027 PTCL futility analysis and Q3 2027 AD topline data for soquelitinib

seeking alphaimportance 0.40trust 0.70Corvus Pharmaceuticals, Inc. +0.10soquelitinib +0.10

2026-08-06 21:00:40 UTC#140558newconfirmednews

Corvus Pharmaceuticals Q2 adjusted loss of $0.19/share misses analyst estimate of $0.16 loss

reutersimportance 0.40trust 0.90Corvus Pharmaceuticals, Inc. -0.40

2026-07-22 20:03:01 UTC#65135newconfirmednews

Ian T. Clark resigns from Corvus Pharmaceuticals board of directors effective July 22, 2026

tradingviewimportance 0.30trust 0.90Corvus Pharmaceuticals, Inc. -0.20Ian T. Clark 0